ALTRENO (TRETINOIN) — FDA Approval NDA209353 (DOW PHARM)
ALTRENO (TRETINOIN) — FDA Approval NDA209353 (DOW PHARM) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ALTRENO; Active ingredients: TRETINOIN; Application number: NDA209353.
| Brand name | ALTRENO |
|---|---|
| Active ingredients | TRETINOIN |
| Application number | NDA209353 |
| Sponsor | DOW PHARM |
| Dosage form | LOTION |
| Route | TOPICAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20180823 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →